We are live on
!
Find out more
MG
Meditor Group Portfolio holdings
AUM
$48.1M
1-Year Est. Return
38.67%
This Fund
S&P 500
This Quarter
Est. Return
-14.99%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$290M
AUM Growth
-$60.2M
(-17%)
Cap. Flow
-$11.2M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelixis
EXEL
|
+$10.7M |
| 2 |
Alkermes
ALKS
|
+$500K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 96.06% |
Similar funds
BHCM
VMV
BHH
LAMC
MAM
BCM
LOF
CLCM
Meditor Group's Q1 2020 Portfolio in Review
As of Q1 2020, Meditor Group held 6 positions worth $290M, down 17% from $351M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Meditor Group withdrew a net $11.2M in Q1 2020, reducing 2 holdings. Its largest reduction was Exelixis, cutting an estimated $10.7M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.
- Meditor Group's biggest Q1 2020 reduction was Exelixis, cutting an estimated $10.7M.
- Meditor Group's ten largest holdings make up 100% of its $290M portfolio in Q1 2020.
- Meditor Group opened 0 new positions and closed 0 in Q1 2020.
- Meditor Group's portfolio value fell 17% quarter-over-quarter to $290M.
Based on Meditor Group's 13F filing for Q1 2020, filed 30 Apr 2020.